- |||||||||| TheraCIM (nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
New P1/2 trial, Metastases: A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer (clinicaltrials.gov) - Mar 20, 2014 P1/2, N=15, Active, not recruiting,
- |||||||||| Trial termination: Intracutaneous Sterile Water Injections (clinicaltrials.gov) - Mar 16, 2014
P=N/A, N=8, Terminated, Not yet recruiting --> Recruiting Recruiting --> Terminated; low qualified candidate enrollment
- |||||||||| Enrollment change: Intracutaneous Sterile Water Injections (clinicaltrials.gov) - Mar 16, 2014
P=N/A, N=8, Terminated, Recruiting --> Terminated; low qualified candidate enrollment N=200 --> 8
- |||||||||| Norditropin (somatropin) / Novo Nordisk, Cetrotide (cetrorelix) / EMD Serono
Trial initiation date: IVF/ICSI Protocols in Poor Responders With Growth Hormone (clinicaltrials.gov) - Mar 3, 2014 P4, N=287, Recruiting, Active, not recruiting --> Completed Initiation date: Jul 2011 --> Sep 2013
|